Skip to content

Application of Remazolam toluenesulfonic acid in laparoscopic anesthesia for elderly patients

Application of Remazolam toluenesulfonic acid in laparoscopic anesthesia for elderly patients

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000039392
Enrollment
Unknown
Registered
2020-10-25
Start date
2020-11-01
Completion date
Unknown
Last updated
2021-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Senile laparoscope

Interventions

Control group :Propofol 4mg/kg/h
The research group A:Remazolam toluenesulfonic acid 1mg/kg/h
The research group B:Remazolam toluenesulfonic acid 2mg/kg/h
The research group C:Remazolam toluenesulfonic acid 3mg/kg/h

Sponsors

Tangshan Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 75 Years

Inclusion criteria

Inclusion criteria: Laparoscopic surgery patients with ASA II - III level; Ages 60-75 years, regardless of gender; The operation lasts 2-3 hours.

Exclusion criteria

Exclusion criteria: 1. Those with incomplete clinical examination data and researchers think it is inappropriate to participate in this study. 2. MAP < 50mmHg and heart rate (H R) < 60 times /min were excluded for severe cardiopulmonary function, coagulation dysfunction, hemodynamic instability and other diseases. 3. Hypertensive patients whose blood pressure is not satisfactorily controlled by antihypertensive drugs; 4. Patients with water and electrolyte disturbances, severe atrioventricular block and severe cardiac insufficiency; 5. Patients with drug intolerance or allergy are known in this study; 6. Patients with peripheral vascular diseases, recent use of vasoactive drugs, antidepressants and painkillers; 7. Have a history of brain injury, intracranial hypertension, cerebral aneurysm, cerebrovascular accident and central nervous system disease.

Design outcomes

Primary

MeasureTime frame
Mean arterial pressure, heart rate, blood oxygen saturation, and BIS;Induction duration and intubation time;Postoperative eye opening time, consciousness recovery time, PACU residence time and directional force recovery time;

Secondary

MeasureTime frame
Occurrence of intraoperative and postoperative adverse reactions;

Countries

China

Contacts

Public ContactYanrong Xu

Department of Anesthesiology, Tangshan Central Hospital

xyrfs@126.com+86 18532660166

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026